When researchers in the U.S. and the UK set out to map the hotspots they looked for both the exotic and the mundane. They also took into account the relative lack of monitoring and reporting of disease outbreaks in underdeveloped nations to give a clearer idea of where, and how often, diseases were making the jump from wildlife to humans. In the end, they discovered that emerging infections in developing nations tended to be novel pathogens, encountered as humans squeeze further into previously uninhabited regions and have more contact with the wildlife found there. Conversely, the emerging infections in the developed world were primarily drug-resistant pathogens, bred by widespread antibiotic use in the human and livestock populations. Additionally, the majority of the hotspots were found in the developing world. Unfortunately, most of the funding for monitoring and prevention is allocated to the developed world.